Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
- Status
- UNKNOWN
- Phase
- PHASE2
Folfox-B Study for Patients With Colorectal Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I FOLFOX Combination
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1